Authors: GOLDWASSER F GROSS M CHOUAKI N BUTHAUD X RIOFRIO M TIGAUD JM RISSE ML MISSET JL CVITKOVIC E

Citation: F. Goldwasser et al., OXALIPLATINE (L-OHP) CPT11 COMBINATION EVERY 2 WEEKS - RESULTS OF AN ONGOING PHASE-I STUDY IN ADVANCED DIGESTIVE MALIGNANCIES/, Annals of oncology, 9, 1998, pp. 234-234

Authors: GROSS M CVITKOVIC E WASSERMAN E GOLDWASSER F CHOUAKI N RIOFRIO M OULDKACI M TIGAUD JM MIGNARD D MISSET JL

Citation: M. Gross et al., CPT-11 OXALIPLATIN (L-OHP) COMBINATION - COMPARISON OF THE TOXICITY OF 2 SCHEDULES OF ADMINISTRATION/, Annals of oncology, 9, 1998, pp. 262-262

Authors: ROUGIER P PAILLOT B LAPLANCHE A MORVAN F SEITZ JF REKACEWICZ C LAPLAIGE P JACOB J GRANDJOUAN S TIGAUD JM FABRI MC LUBOINSKI M DUCREUX M

Citation: P. Rougier et al., 5-FLUOROURACIL (5-FU) CONTINUOUS INTRAVENOUS-INFUSION COMPARED WITH BOLUS ADMINISTRATION - FINAL RESULTS OF A RANDOMIZED TRIAL IN METASTATIC COLORECTAL-CANCER, European journal of cancer, 33(11), 1997, pp. 1789-1793

Authors: SUTTON L CHASTANG C RIBAUD P JOUET JP KUENTZ M ATTAL M REIFFERS J TIGAUD JM RIO B DAURIAC C LEGROS M DREYFUS F LIOURE B TROUSSARD X MILPIED N WITZ F ORIOL P CAHN JY MICHALLET M GLUCKMAN E IFRAH N PICO JL VILMER E LEBLOND V

Citation: L. Sutton et al., FACTORS INFLUENCING OUTCOME IN DE-NOVO MYELODYSPLASTIC SYNDROMES TREATED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION - A LONG-TERM STUDY OF 71 PATIENTS, Blood, 88(1), 1996, pp. 358-365

Authors: MAHJOUBI M ROUGIER P OLIVIERA J HERAIT P TIGAUD JM DROZ JP

Citation: M. Mahjoubi et al., PHASE-II TRIAL OF PIRARUBICIN IN THE TREATMENT OF ADVANCED PANCREATIC-CANCER, Cancer investigation, 12(4), 1994, pp. 403-405